Approval · Notice of Compliance 8143 · 2006
LINCOMYCIN 44 PREMIX: Notice of Compliance 8143
Issued July 12, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8143
- Date
- July 12, 2006
- Company
- Bio Agri Mix LpMitchell, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Change in withdrawal period
- Therapeutic class
- Antibiotic
- Canadian reference product
- LINCOMIX 44 PREMIX (Pfizer Canada Inc., Animal Health Group)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINCOMYCIN 44 PREMIX | 02085844 | Dormant |
Medicinal ingredients
- LINCOMYCIN HYDROCHLORIDE 44 G per KG